Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 544

The DOI matches its Crossref record.

Cervical cancer and use of hormonal contraceptives: a systematic review

Smith, Jennifer S, Green, Jane, de Gonzalez, Amy Berrington, Appleby, Paul, Peto, Julian, Plummer, Martyn, Franceschi, Silvia, Beral, Valerie·2003·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(03)12949-2

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 46

  1. Walboomers, 1999, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, 189, 12, 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F · doi:10.1002/(sici)1096-9896(199909)189:1<12::aid-path431>3.0.co;2-f
  2. 1995, Human Papillomaviruses, IARC Monogr Eval Carcinog Risks Hum, 64, 1
  3. Moreno, 2002, Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study, Lancet, 359, 1085, 10.1016/S0140-6736(02)08150-3 · DOI · Paper page
  4. Skegg, 2002, Oral contraceptives, parity, and cervical cancer, Lancet, 359, 1080, 10.1016/S0140-6736(02)08125-4 · doi:10.1016/s0140-6736(02)08125-4
  5. 1999, Hormonal contraception and post-menopausal hormonal therapy. Lyon, International Agency for Research on Cancer, IARC Monogr Eval Carcinog Risks Hum, 72, 49
  6. Hildesheim, 2001, HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica, Br J Cancer, 84, 1219, 10.1054/bjoc.2001.1779 · DOI · Paper page
  7. Berrington A, Cox DR. Generalised least squares for the synthesis of correlated information. Biostatistics (in press).
  8. Brinton, 1986, Long-term use of oral contraceptives and risk of invasive cervical cancer, Int J Cancer, 38, 399, 10.1002/ijc.2910380307 · doi:10.1002/ijc.2910380307
  9. Jones, 1990, Risk factors for in situ cervical cancer: results from a case-control study, Cancer Res, 50, 3657
  10. Peters, 1986, Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County, J Natl Cancer Inst, 77, 1063
  11. Ebeling, 1987, Use of oral contraceptives and risk of invasive cervical cancer in previously screened women, Int J Cancer, 39, 427, 10.1002/ijc.2910390402 · doi:10.1002/ijc.2910390402
  12. Beral, 1988, Oral contraceptive use and malignancies of the genital tract: results from the Royal College of General Practitioners' Oral Contraception Study, Lancet, 2, 1331, 10.1016/S0140-6736(88)90869-0 · DOI · Paper page
  13. Irwin, 1988, Oral contraceptives and cervical cancer risk in Costa Rica: detection bias or causal association?, JAMA, 259, 59, 10.1001/jama.1988.03720010037037 · doi:10.1001/jama.1988.03720010037037
  14. Oberle, 1988, Cervical cancer risk and use of DMPA in Costa Rica, Int J Epidemiol, 17, 718, 10.1093/ije/17.4.718 · doi:10.1093/ije/17.4.718
  15. Brinton, 1990, Oral contraceptive use and risk of invasive cervical cancer, Int J Epidemiol, 19, 4, 10.1093/ije/19.1.4 · DOI
  16. Herrero, 1990, Injectable contraceptives and risk of invasive cervical cancer: evidence of an association, Int J Cancer, 46, 5, 10.1002/ijc.2910460103 · doi:10.1002/ijc.2910460103
  17. Kjaer, 1993, Case-control study of risk factors for cervical squamous-cell neoplasia in Denmark. III. Role of oral contraceptive use, Cancer Causes Control, 4, 513, 10.1007/BF00052426 · doi:10.1007/bf00052426
  18. 1993, Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Int J Cancer, 55, 228, 10.1002/ijc.2910550211 · doi:10.1002/ijc.2910550211
  19. Ursin, 1994, Oral contraceptive use and adenocarcinoma of cervix, Lancet, 344, 1390, 10.1016/S0140-6736(94)90567-3 · DOI
  20. Lazcano-Ponce, 1995, [Reproductive risk factors and sexual history associated with cervical cancer in Mexico], Revista de Investigacion Clinica, 47, 377
  21. Cuzick, 1996, Risk factors for invasive cervix cancer in young women, Eur J Cancer, 32A, 836, 10.1016/0959-8049(95)00650-8 · DOI
  22. Daling, 1996, The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection, Cancer Epidemiol Biomarkers Prev, 5, 541
  23. Zondervan, 1996, Oral contraceptives and cervical cancer: further findings from the Oxford Family Planning Association contraceptive study, Br J Cancer, 73, 1291, 10.1038/bjc.1996.247 · doi:10.1038/bjc.1996.247
  24. Parazzini, 1998, Time since last use of oral contraceptives and risk of invasive cervical cancer, Eur J Cancer, 34, 884, 10.1016/S0959-8049(97)10139-3 · doi:10.1016/s0959-8049(97)10139-3
  25. Lacey, 1999, Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas, Cancer Epidemiol Biomarkers Prev, 8, 1079
  26. Ylitalo, 1999, Smoking and oral contraceptives as risk factors for cervical carcinoma in situ, Int J Cancer, 81, 357, 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.0.CO;2-1 · DOI
  27. Deacon, 2000, Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort, Br J Cancer, 83, 1565, 10.1054/bjoc.2000.1523 · DOI · Paper page
  28. Madeleine, 2001, Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix, Cancer Epidemiol Biomarkers Prev, 10, 171
  29. Berrington, 2002, Oral contraceptives and cervical cancer, Lancet, 360, 410, 10.1016/S0140-6736(02)09578-8 · doi:10.1016/s0140-6736(02)09578-8
  30. Bosch, 1992, Risk factors for cervical cancer in Colombia and Spain, Int J Cancer, 52, 750, 10.1002/ijc.2910520514 · DOI · Paper page
  31. Munoz, 1992, The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain, Int J Cancer, 52, 743, 10.1002/ijc.2910520513 · DOI · Paper page
  32. Bosch, 1993, Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia, Cancer Epidemiol Biomarkers Prev, 2, 415
  33. Munoz, 1993, Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia, Cancer Epidemiol Biomarkers Prev, 2, 423
  34. Eluf-Neto, 1994, Human papillomavirus and invasive cervical cancer in Brazil, Br J Cancer, 69, 114, 10.1038/bjc.1994.18 · DOI · Paper page
  35. Chaouki, 1998, The viral origin of cervical cancer in Rabat, Morocco, Int J Cancer, 75, 546, 10.1002/(SICI)1097-0215(19980209)75:4<546::AID-IJC9>3.0.CO;2-T · DOI
  36. Chichareon, 1998, Risk factors for cervical cancer in Thailand: a case-control study, J Natl Cancer Inst, 90, 50, 10.1093/jnci/90.1.50 · DOI · Paper page
  37. Ngelangel, 1998, Causes of cervical cancer in the Philippines: a case-control study, J Natl Cancer Inst, 90, 43, 10.1093/jnci/90.1.43 · DOI · Paper page
  38. Rolon, 2000, Human papillomavirus infection and invasive cervical cancer in Paraguay, Int J Cancer, 85, 486, 10.1002/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S · DOI
  39. Santos, 2001, HPV types and cofactors causing cervical cancer in Peru, Br J Cancer, 85, 966, 10.1054/bjoc.2001.1948 · DOI
  40. 1992, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 45, 299, 10.1016/0010-7824(92)90052-U · DOI
  41. Thomas, 1995, Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 52, 307, 10.1016/0010-7824(95)00215-V · DOI
  42. Thomas, 1995, Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Contraception, 51, 25, 10.1016/0010-7824(94)00007-J · DOI
  43. Ye, 1995, Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives, Int J Epidemiol, 24, 19, 10.1093/ije/24.1.19 · doi:10.1093/ije/24.1.19
  44. Thomas, 1996, Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives, Am J Epidemiol, 144, 281, 10.1093/oxfordjournals.aje.a008923 · doi:10.1093/oxfordjournals.aje.a008923
  45. 1996, Breast cancer and hormonal contraceptives: further results, Contraception, 54, 1S
  46. Green J, Berrington de Gonzalez A, Smith JS, et al. Human papillomavirus and use of oral contraceptives. Br J Cancer (in press).

Cited by

See all 544

Metadata

Authors
Smith, J. S., Green, J., de Gonzalez, A. B., Appleby, P., Peto, J., Plummer, M., Franceschi, S., & Beral, V.
Venue
The Lancet
Publisher
Elsevier BV
Published
2003-04
Volume
361
Issue
9364
Pages
1159-1167
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2142116340
Cited by
544
References
0
FWCI
4.70
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cervical cancer and use of hormonal contraceptives: a systematic review. https://app.cochat.ai/papers/10.1016/s0140-6736(03)12949-2
The paper
Smith, J. S., Green, J., de Gonzalez, A. B., Appleby, P., Peto, J., Plummer, M., Franceschi, S., & Beral, V. (2003). Cervical cancer and use of hormonal contraceptives: a systematic review. The Lancet. https://doi.org/10.1016/s0140-6736(03)12949-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.